Catalyst
Slingshot members are tracking this event:
Eagle Pharma (EGRX) Submits Rolling New Drug Application (NDA) to FDA Seeking Approval of Ryanodex in Exertional Heat Stroke
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EGRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rolling New Drug Application, Nda, Fda, Ryanodex, Exertional Heat Stroke
